On March 29, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven drug discovery and development, announced a landmark collaboration with…
Read More
Amazon Bio Discovery Cuts MSK Antibody Design from a Year to Weeks, AWS Says
Amazon Web Services (AWS) has announced the launch of Amazon Bio Discovery, a sophisticated application designed to significantly accelerate the…
Read More
Immuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure Throughput
In a significant development poised to accelerate drug discovery, Immuto Scientific, a biotech firm co-founded in 2018 by CEO Faraz…
Read More
Lilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?
Eli Lilly and Company, a pharmaceutical giant currently experiencing unprecedented growth driven by its blockbuster GLP-1 agonists, has announced its…
Read More
EClinical Solutions study models 241% ROI from AI-powered clinical trial data platform
The pharmaceutical industry, perpetually grappling with the escalating costs and protracted timelines of drug development, is witnessing a significant paradigm…
Read More
Chinese Biotechs Emerge as Global Pharma Powerhouses, Securing One-Third of Major Deal Value in 16 Months
Over the past sixteen months, Chinese-domiciled biotechnology companies have solidified their position as pivotal players in the global pharmaceutical landscape,…
Read More
A decade in the making: How functional NAMs are redefining cardiac safety assessment
The rapid acceleration of New Approach Methodologies (NAMs) in drug safety testing has, for many, appeared to be a sudden…
Read More
BioNTech Pivots Dramatically to Oncology Amidst Waning Vaccine Revenue and Federal Shift, Cutting 1,860 Jobs and Investing €16.8 Billion in Cash
The German biotechnology powerhouse BioNTech, once synonymous with its groundbreaking COVID-19 vaccine, Comirnaty, is undergoing a profound strategic transformation, shedding…
Read More
Deloitte Report Reveals Pharma R&D Returns Surge to 7% Driven Primarily by GLP-1 Blockbusters, Raising Sustainability Concerns
A new report from Deloitte, titled "Navigating the GLP-1 boom," indicates a significant resurgence in biopharma R&D productivity, with the…
Read More
BD, Wellstar Connect Pharmacy-to-Bedside Medication Management with AI
BD, a global leader in medical technology, has announced a landmark partnership with Wellstar Health System, one of Georgia’s largest…
Read MoreYOU MAY HAVE MISSED
